Specific safety and tolerability considerations in the use of anticonvulsant medications in children

Amy Z Crepeau,1 Brian D Moseley,2 Elaine C Wirrell31Division of Epilepsy, Department of Neurology, Mayo Clinic, 2Department of Neurology, Mayo Clinic, 3Divisions of Epilepsy and Child and Adolescent Neurology, Mayo Clinic, Rochester, MN, USAAbstract: Epilepsy is one of the most common neurological d...

Full description

Bibliographic Details
Main Authors: Crepeau A, Moseley BD, Wirrell EC
Format: Article
Language:English
Published: Dove Medical Press 2012-06-01
Series:Drug, Healthcare and Patient Safety
Online Access:http://www.dovepress.com/specific-safety-and-tolerability-considerations-in-the-use-of-anticonv-a10048
id doaj-009e2ca1af3a46118b4d30822346a9a5
record_format Article
spelling doaj-009e2ca1af3a46118b4d30822346a9a52020-11-24T23:22:45ZengDove Medical PressDrug, Healthcare and Patient Safety1179-13652012-06-012012default3954Specific safety and tolerability considerations in the use of anticonvulsant medications in childrenCrepeau AMoseley BDWirrell ECAmy Z Crepeau,1 Brian D Moseley,2 Elaine C Wirrell31Division of Epilepsy, Department of Neurology, Mayo Clinic, 2Department of Neurology, Mayo Clinic, 3Divisions of Epilepsy and Child and Adolescent Neurology, Mayo Clinic, Rochester, MN, USAAbstract: Epilepsy is one of the most common neurological disorders in the pediatric age range, and the majority of affected children can be safely and effectively treated with antiepileptic medication. While there are many antiepileptic agents on the market, specific drugs may be more efficacious for certain seizure types or electroclinical syndromes. Furthermore, certain adverse effects are more common with specific classes of medication. Additionally patient-specific factors, such as age, race, other medical conditions, or concurrent medication use may result in higher rates of side effects or altered efficacy. Significant developmental changes in gastric absorption, protein binding, hepatic metabolism, and renal clearance are seen over the pediatric age range, which impact pharmacokinetics. Such changes must be considered to determine optimal dosing and dosing intervals for children at specific ages. Furthermore, approximately one third of children require polytherapy for seizure control, and many more take concurrent medications for other conditions. In such children, drug–drug interactions must be considered to minimize adverse effects and improve efficacy. This review will address issues of antiepileptic drug efficacy, tolerability and ease of use, pharmacokinetics, and drug–drug interactions in the pediatric age range.Keywords: antiepileptic drugs, drug–drug interactions, pharmacokineticshttp://www.dovepress.com/specific-safety-and-tolerability-considerations-in-the-use-of-anticonv-a10048
collection DOAJ
language English
format Article
sources DOAJ
author Crepeau A
Moseley BD
Wirrell EC
spellingShingle Crepeau A
Moseley BD
Wirrell EC
Specific safety and tolerability considerations in the use of anticonvulsant medications in children
Drug, Healthcare and Patient Safety
author_facet Crepeau A
Moseley BD
Wirrell EC
author_sort Crepeau A
title Specific safety and tolerability considerations in the use of anticonvulsant medications in children
title_short Specific safety and tolerability considerations in the use of anticonvulsant medications in children
title_full Specific safety and tolerability considerations in the use of anticonvulsant medications in children
title_fullStr Specific safety and tolerability considerations in the use of anticonvulsant medications in children
title_full_unstemmed Specific safety and tolerability considerations in the use of anticonvulsant medications in children
title_sort specific safety and tolerability considerations in the use of anticonvulsant medications in children
publisher Dove Medical Press
series Drug, Healthcare and Patient Safety
issn 1179-1365
publishDate 2012-06-01
description Amy Z Crepeau,1 Brian D Moseley,2 Elaine C Wirrell31Division of Epilepsy, Department of Neurology, Mayo Clinic, 2Department of Neurology, Mayo Clinic, 3Divisions of Epilepsy and Child and Adolescent Neurology, Mayo Clinic, Rochester, MN, USAAbstract: Epilepsy is one of the most common neurological disorders in the pediatric age range, and the majority of affected children can be safely and effectively treated with antiepileptic medication. While there are many antiepileptic agents on the market, specific drugs may be more efficacious for certain seizure types or electroclinical syndromes. Furthermore, certain adverse effects are more common with specific classes of medication. Additionally patient-specific factors, such as age, race, other medical conditions, or concurrent medication use may result in higher rates of side effects or altered efficacy. Significant developmental changes in gastric absorption, protein binding, hepatic metabolism, and renal clearance are seen over the pediatric age range, which impact pharmacokinetics. Such changes must be considered to determine optimal dosing and dosing intervals for children at specific ages. Furthermore, approximately one third of children require polytherapy for seizure control, and many more take concurrent medications for other conditions. In such children, drug–drug interactions must be considered to minimize adverse effects and improve efficacy. This review will address issues of antiepileptic drug efficacy, tolerability and ease of use, pharmacokinetics, and drug–drug interactions in the pediatric age range.Keywords: antiepileptic drugs, drug–drug interactions, pharmacokinetics
url http://www.dovepress.com/specific-safety-and-tolerability-considerations-in-the-use-of-anticonv-a10048
work_keys_str_mv AT crepeaua specificsafetyandtolerabilityconsiderationsintheuseofanticonvulsantmedicationsinchildren
AT moseleybd specificsafetyandtolerabilityconsiderationsintheuseofanticonvulsantmedicationsinchildren
AT wirrellec specificsafetyandtolerabilityconsiderationsintheuseofanticonvulsantmedicationsinchildren
_version_ 1725566490022772736